** Shares of Kromek Group Plc KMK.L gain as much as 30% to
7p; stock set to post best day since April 2014, if trend holds
** The developer of radiation and bio-detection tech
products for advanced imaging sees substantial revenue growth
for FY23 vs FY22
** Co sees FY gross margin in its traditional high-40s
percentile and expects to be EBITDA positive for H2 2023
** Says Q3 revenue about 50% higher than a year earlier
** Separately, co enters into an initial seven-year
agreement with a health-technology firm to develop
detectors for use in advanced medical imaging scanners
** Stock last down 18%, taking YTD losses to about 44%
(Reporting by Aby Jose Koilparambil in Bengaluru)
((abyjose.koilparambil@thomsonreuters.com))